Check out your Company Bowl for anonymous work chats.
We are thrilled to announce an exclusive partnership with ChemoMouthpiece, LLC to support the U.S. launch and commercialization of their medical device, which helps cancer patients proactively manage and treat oral mucositis (OM) during chemotherapy. Learn more: http://ow.ly/mTjC50NopWl
New Partnership with ChemoMouthpiece, LLC to Support U.S. Launch & Commercialization of Novel Oncology Medical Device
When clients have a pressing issue and are unsure of the best course of action, having a team of advisors and researchers at the ready can mean the difference between simply passing and succeeding. Trusted experts like Heather Rae Martin, STEM MBA Healthcare Strategist, Associate Principal at EVERSANA CONSULTING, are the “Pharma Wayfinders” for our partners. Read on to learn her surprising favorite part of the consulting lifecycle, advice on entering the field and more in our most recent career blog! http://ow.ly/ZK8f50NoYtJ
A Day in the Life: Heather Rae Martin, Pharma Wayfinder
We’re thrilled to announce that EVERSANA has been named the knowledge partner by Asia Pacific Medical Technology Association (APACMed) to help shape digital health reimbursement throughout Asia Pacific countries. Together we’ll help develop a framework to support innovative reimbursement models for digital health companies as they work with policymakers to ensure better access to new and transformative therapies, diagnostic aids and patient management solutions. Learn more: http://ow.ly/XuIv50Nopf8
APACMed Names EVERSANA® Knowledge Partner to Shape Digital Health Reimbursement Framework Across Region
Congratulations to Lisa Stafford, SVP Learning & Performance, Field Deployment Solutions, for being named as an MM+M Woman to Watch honoree and Susan Perlbachs, Chief Creative Officer, EVERSANA INTOUCH as a Woman of Distinction winner. We appreciate your leadership and dedication to the industry and can't wait to celebrate at this year's Women of Distinction event on May 15, 2023.
MM+M names 2023 classes of Women of Distinction, Women to Watch
AI-driven marketing automation is growing more mature by the day. Chief Innovation Officer Faruk Capan spoke with Med Ad News about how this approach helps pharma marketers better understand customers & tailor marketing efforts accordingly. Read more:
Rise of the Machines
Keeping up with pharma news and trending topics isn’t easy. But keeping tabs on each country’s unique decisions and their impact on businesses? That’s another story. Read on to see how EVERSANA’s Anna Smith, Head of News for NAVLIN Daily, stays on top of it all as the “Trend Detective,” advice for those looking to pursue a career in pharma journalism and more:
A Day in the Life: Anna Smith, the Trend Detective for NAVLIN Daily
At EVERSANA, our teams are shining bright for #RareDiseaseDay! Check out a smattering of patient minded and colorful colleagues who participated in our company-wide events.
At EVERSANA, our teams are shining bright for #RareDiseaseDay! Check out a smattering of patient minded and colorful colleagues who participated in our company-wide events.
More than 400 million individuals worldwide are living with a #RareDisease. Just like EVERSANA CEO Jim Lang, you may be touched personally by rare disease on this #RareDiseaseDay. EVERSANA’s mission supports these efforts, as we are committed to advancing the commercialization of rare and orphan drugs to improve patient outcomes for all. http://ow.ly/Tcft50N1bXz DID YOU KNOW? - The average time to get an accurate rare diagnosis is 6-8 years. - 95% of rare diseases lack an FDA-approved treatment. - Rare diseases impact more people than #cancer and #AIDS combined. - 70% of rare diseases start in childhood and all #pediatric cancers are rare cancers.
How EVERSANA is Advancing the Commercialization of Rare & Orphan Drugs
Read our Q&A with EVERSANA's Brian Abraham, Sr. Director of Market Access & Patient Services and CureMatch, Inc. CEO, Navid Alipour, about how our partnership resulted in a new CPT® code for CureMatch's pharma-oncologic treatment Digital Health algorithm, which provides ranked, targeted drug treatments for #cancer patients:
Read the Q&A Now!
Chief Digital Officer Scott Snyder recently spoke on the MM+M podcast about all things digital health and how EVERSANA is working to disrupt the traditional healthcare landscape to better patients’ lives. Listen to the full podcast to learn more!
MM+M Podcast 2.8.23: Eisai's pricing transparency, GAO's report on 'gain-of-function' research and MrBeast's polarizing video